Search research articles
Contact Us
Filters
Showing results (11-20 of 89) with videos related to
Page
of 9
Sort By:
Nuclear Medicine and Biology
|
April 20, 2004
Synthesis, radioiodination, and biodistribution of some nido- and closo-monocarbon carborane derivatives
D Scott Wilbur, Donald K Hamlin, Rajiv R Srivastava, et al.
Bioconjugate Chemistry
|
December 13, 2007
Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At
D Scott Wilbur, Donald K Hamlin, Ming-Kuan Chyan, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
August 2, 2007
211AtCl@US-tube nanocapsules: a new concept in radiotherapeutic-agent design
Keith B Hartman, Donald K Hamlin, D Scott Wilbur, et al.
Bioconjugate Chemistry
|
April 26, 2011
Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention
D Scott Wilbur, Ming-Kuan Chyan, Donald K Hamlin, et al.
Nuclear Medicine and Biology
|
May 16, 2020
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer
Yawen Li, Ming-Kuan Chyan, Donald K Hamlin, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Oxidation of <i>p</i>-[<sup>125</sup>I]Iodobenzoic Acid and <i>p</i>-[<sup>211</sup>At]Astatobenzoic Acid Derivatives and Evaluation In Vivo
Yawen Li, Ming-Kuan Chyan, Donald K Hamlin, et al.
Nuclear Medicine and Biology
|
February 15, 2017
Development of a preclinical <sup>211</sup>Rn/<sup>211</sup>At generator system for targeted alpha therapy research with <sup>211</sup>At
Jason R Crawford, Hua Yang, Peter Kunz, et al.
Bioconjugate Chemistry
|
May 20, 2004
Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives
D Scott Wilbur, Donald K Hamlin, Ming-Kuan Chyan, et al.
Oncology Reports
|
March 29, 2007
Biodistribution of 211At labeled HER-2 binding affibody molecules in mice
Ann-Charlott Steffen, Ylva Almqvist, Ming-Kuan Chyan, et al.
Scientific Reports
|
January 1, 2020
Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets
Matthew J O'Hara, Anthony J Krzysko, Donald K Hamlin, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 89) with videos related to
Sort By:
Page
of 9
Nuclear Medicine and Biology
|
April 20, 2004
Synthesis, radioiodination, and biodistribution of some nido- and closo-monocarbon carborane derivatives
D Scott Wilbur, Donald K Hamlin, Rajiv R Srivastava, et al.
Bioconjugate Chemistry
|
December 13, 2007
Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At
D Scott Wilbur, Donald K Hamlin, Ming-Kuan Chyan, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
August 2, 2007
211AtCl@US-tube nanocapsules: a new concept in radiotherapeutic-agent design
Keith B Hartman, Donald K Hamlin, D Scott Wilbur, et al.
Bioconjugate Chemistry
|
April 26, 2011
Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention
D Scott Wilbur, Ming-Kuan Chyan, Donald K Hamlin, et al.
Nuclear Medicine and Biology
|
May 16, 2020
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer
Yawen Li, Ming-Kuan Chyan, Donald K Hamlin, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Oxidation of <i>p</i>-[<sup>125</sup>I]Iodobenzoic Acid and <i>p</i>-[<sup>211</sup>At]Astatobenzoic Acid Derivatives and Evaluation In Vivo
Yawen Li, Ming-Kuan Chyan, Donald K Hamlin, et al.
Nuclear Medicine and Biology
|
February 15, 2017
Development of a preclinical <sup>211</sup>Rn/<sup>211</sup>At generator system for targeted alpha therapy research with <sup>211</sup>At
Jason R Crawford, Hua Yang, Peter Kunz, et al.
Bioconjugate Chemistry
|
May 20, 2004
Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl- and nido-carboranyl-biotin derivatives
D Scott Wilbur, Donald K Hamlin, Ming-Kuan Chyan, et al.
Oncology Reports
|
March 29, 2007
Biodistribution of 211At labeled HER-2 binding affibody molecules in mice
Ann-Charlott Steffen, Ylva Almqvist, Ming-Kuan Chyan, et al.
Scientific Reports
|
January 1, 2020
Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets
Matthew J O'Hara, Anthony J Krzysko, Donald K Hamlin, et al.
Page
of 9